Maskless Writing of Surface-Attached Micro-Magnets by Two-Photon Crosslinking
Actuators · 15.03.2023 · 12 (3) · 124
DOI: 10.3390/act12030124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Actuators, online erschienen am 15.03.2023. Verfasst von Nicolas Geid und 3 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).
Abstract (Originalsprache)
Surface-bound 3D micro-magnets are fabricated from photoreactive copolymers filled with magnetic nanoparticles by maskless 3D writing. The structures are generated by 2-photon crosslinking (2PC), which allows direct writing into solid films of composites consisting of magnetic particles and a photoreactive elastomer precursor. With this strategy, it is possible to directly write complex, surface-bound magnetic actuator structures, which generates new opportunities in the fields of microfluidics and bioanalytical systems. Compared to the common 2-photon polymerization, in which the writing process takes place in a liquid resin, the direct writing based on the 2PC method takes place in a solid polymer film (i.e., in the glassy state).
Förderung
- Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
Zitieren
APA
Geid, N., Leutner, J. U., Prucker, O., & Rühe, J. (2023). Maskless Writing of Surface-Attached Micro-Magnets by Two-Photon Crosslinking. Actuators, 12(3), 124. https://doi.org/10.3390/act12030124
Vancouver
Geid N, Leutner JU, Prucker O, Rühe J. Maskless Writing of Surface-Attached Micro-Magnets by Two-Photon Crosslinking. Actuators. 2023;12(3):124. doi:10.3390/act12030124
BibTeX
@article{Geid2023,
author = {Geid, Nicolas and Leutner, Jan Ulrich and Prucker, Oswald and Rühe, Jürgen},
title = {Maskless Writing of Surface-Attached Micro-Magnets by Two-Photon Crosslinking},
journal = {Actuators},
year = {2023},
volume = {12},
number = {3},
pages = {124},
doi = {10.3390/act12030124}
}
EUVIMED